Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KOSDAQ - Delayed Quote KRW

RP Bio Inc. (314140.KQ)

5,500.00
-40.00
(-0.72%)
At close: May 2 at 3:30:30 PM GMT+9
Loading Chart for 314140.KQ
  • Previous Close 5,540.00
  • Open 5,520.00
  • Bid 5,460.00 x --
  • Ask 5,500.00 x --
  • Day's Range 5,470.00 - 5,640.00
  • 52 Week Range 4,560.00 - 10,790.00
  • Volume 23,237
  • Avg. Volume 119,478
  • Market Cap (intraday) 47.574B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, and chewable soft capsules; non-synthetic and chewable tablets; hard capsules and jelly sticks; and granule, effervescent granule, and stick type capsule powders. The company was founded in 1983 and is based in Seoul, South Korea.

www.rpcorp.co.kr

Recent News: 314140.KQ

View More

Performance Overview: 314140.KQ

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

314140.KQ
8.91%
KOSPI Composite Index (^KS11)
6.68%

1-Year Return

314140.KQ
40.73%
KOSPI Composite Index (^KS11)
4.62%

3-Year Return

314140.KQ
71.50%
KOSPI Composite Index (^KS11)
4.75%

5-Year Return

314140.KQ
71.50%
KOSPI Composite Index (^KS11)
31.44%

Compare To: 314140.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 314140.KQ

View More

Valuation Measures

Annual
As of 5/2/2025
  • Market Cap

    47.57B

  • Enterprise Value

    58.93B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.38

  • Price/Book (mrq)

    0.47

  • Enterprise Value/Revenue

    0.48

  • Enterprise Value/EBITDA

    8.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 314140.KQ

View More

Company Insights: 314140.KQ

Research Reports: 314140.KQ

View More

People Also Watch